HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of dibutyryl cyclic AMP on patients with severe heart failure.

Abstract
Dibutyryl cyclic AMP was administered to 2 patients with severe congestive heart failure. After an intravenous drip infusion of dibutyryl cyclic AMP (300 mg/40 min), marked diuresis and mild improvement of the patients' physical activity occurred. The cardiac index increased and both systemic vascular resistance and pulmonary capillary wedge pressure decreased. Blood glucose and plasma insulin increased simultaneously, while plasma free fatty acid decreased during the infusion. A continuous intravenous micro-infusion of dibutyryl cyclic AMP (300 mg/24 h) also exerted diuresis and improved physical activity. The hemodynamic and metabolic effects of dibutyryl cyclic AMP are expected to be beneficial to a failing heart.
AuthorsH Hashimoto, K Okumura, K Niizoe, K Ogawa
JournalJapanese heart journal (Jpn Heart J) Vol. 23 Issue 6 Pg. 1021-7 (Nov 1982) ISSN: 0021-4868 [Print] Japan
PMID6298483 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Blood Glucose
  • Fatty Acids, Nonesterified
  • Insulin
  • Bucladesine
Topics
  • Adult
  • Blood Glucose (analysis)
  • Bucladesine (administration & dosage, therapeutic use)
  • Fatty Acids, Nonesterified (blood)
  • Heart Failure (drug therapy, physiopathology)
  • Heart Rate (drug effects)
  • Humans
  • Infusions, Parenteral
  • Insulin (blood)
  • Male
  • Middle Aged
  • Pulmonary Wedge Pressure (drug effects)
  • Vascular Resistance (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: